🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine a maximum tolerated dose and/or r...
Status
Completed
Location
Dana Farber Cancer Institute SC (2)
Start Date
2012-04-20
Trial ID
NCT01468688
Sixty % of CML patients treated by Imatinib mesylate achieved a major cytog...
Status
Unknown
Location
Franck NICOLINI
Start Date
2004-03
Trial ID
NCT00146913
Treatments Being Tested
Following the ACOSOG Z9001trial, imatinib received market authorization in ...
Status
Unknown
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT02576080
Treatments Being Tested
This study will determine the safety and effectiveness of AMG 706 in patien...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT00089960
Treatments Being Tested
The objective of this study is to conduct a pilot study using biologic agen...
Status
Completed
Location
Boston Childrens Hospital
Start Date
2008-10
Trial ID
NCT00891527
Treatments Being Tested
This is a phase II, single center, open-label, non randomized clinical stud...
Status
Unknown
Location
Multiple Locations
Start Date
2018-04
Trial ID
NCT02363361
Treatments Being Tested
The investigators will study the effect of imatinib mesylate (Glivec) in tr...
Status
Completed
Location
Department of Dermatology
Start Date
2009-09
Trial ID
NCT00981942
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of tumor cells by blocking...
Status
Completed
Location
Centre Paul Papin
Start Date
2004-09
Trial ID
NCT00287846
Treatments Being Tested
To test the efficacy of a combination chemotherapy of imatinib and 5-FU in ...
Status
Completed
Location
Krankenhaus Nordwest
Start Date
2007-04
Trial ID
NCT01153750
Treatments Being Tested
The primary objective of this trial is to improve the overall survival rate...
Status
Recruiting
Location
Subang Jaya Medical Centre
Start Date
2020-03-04
Trial ID
NCT06336395